Roche seems determined to develop a commanding position in the emerging molecular glue category, signing up to a $2 billion partnership with Monte Rosa Therapeutics that includes a $50 million upfront ...
Big pharma's interest in using protein degradation as a therapeutic strategy continues with a wide-ranging deal between Pfizer and US biotech Triana Biomedicines that could be worth $1.5 billion or ...
Dotz Nano Limited, a nanotechnology company, provides carbon capture and product authentication solutions. It develops, manufactures, and commercializes solutions addressing environmental and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results